French attorney Christophe Jensen turns African American Tia Edwards’ life upside down. She is happier than she’s ever been, but complications arise when Christophe is summoned back to France. Suddenly, the best time of Tia’s life starts falling apart, as she’s forced to choose between her family or her future with a man whose home is in another country. Learn more about this book: http://bit.ly/9ImVi1 Learn more about this author: http://www.karenwhiteowens.com
The closest look into the Googleplex without a badge and ID card, I’m Feeling Lucky is the first inside view of life at Google from one of its original employees, Employee number 59, giving readers a chance to fully experience the bizarre mix of camaraderie and competition at this phenomenal company. Learn more about this book here, http://bit.ly/jyftke and its author here, http://xooglers.blogspot.com/ Non Fiction
First video from ASHLEIGH K. Track Written by ASHLEIGH K & NADEGE BORTIER, Music Produced by ASHLEIGH K, NADEGE BORTIER & MT. STARRING: PETER LUKE YUSUF SERIFI, FEATURING: VICKY LUKE GEMMA EDWARDS, VIDEO PRODUCED BY: DAVID PHILBEY & MARK TIERNEY, Video directed by Mark Tierney for PRIMROSE PRODUCTIONS
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr on receiving the 2015 Institut de France’s Grand Prix Scientifique in a Paris awards ceremony.
The Grand Prix is one of the largest prizes for scientific accomplishment and is considered the world’s most prestigious prize for cardiovascular research. The Institut’s board awarded Starr the Grand Prix in recognition of research that led to the world’s first successful artificial mitral valve implant in 1960. In the last 55 years, millions of patients around the world have benefitted from the emergence of the field of heart valve replacement and the many technological advances that followed.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7536851-france-grand-prix-starr-edwards/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system.
The ClearSight system is a noninvasive monitor that provides clinicians access to valuable blood volume and blood flow information for patients at moderate or high risk of post-surgical complications, in whom invasive monitoring would not be used.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256451-edwards-fda-clearance-for-noninvasive-hemodynamic-monitoring-system/
A new survey from the Gout & Uric Acid Education Society (GUAES) finds many Americans with gout may be placing too much emphasis on diet when it comes to managing the disease and controlling painful flares. Of all the steps taken to manage gout, respondents cited changing their diet by eliminating or reducing consumption of certain foods as their top step taken (50 percent)—even ahead of taking medications to lower their uric acid levels (40 percent) and maintaining an overall healthy fitness level (33 percent). Furthermore, nearly one in three with gout incorrectly believes that the disease can be completely avoided by eliminating certain foods; and more than one in four said they would not take medications if they were making dietary changes.
“Physicians all too often see patients who believe they can successfully manage their gout with diet alone,” said N. Lawrence Edwards, M.D., a rheumatologist and GUAES chairman. “But even with extremely rigid diet restrictions, most gout patients will only be able to lower their uric acid levels slightly—not nearly enough to achieve a healthy level to control flares and reduce risk for long-term damage.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7835451-guaes-diet-survey/
